Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genome Pharmaceutical Industry is an Egyptian pharmaceutical company focused on the development, manufacturing, and marketing of a wide range of generic pharmaceutical products. The company operates a manufacturing facility that produces various dosage forms, including tablets, capsules, and syrups, catering primarily to the Middle East and North Africa (MENA) markets. Their portfolio spans multiple therapeutic areas such as anti-infectives, gastroenterology, and respiratory health. Genome Pharmaceutical aims to provide high-quality, affordable healthcare solutions through its modern production lines and adherence to Good Manufacturing Practices (GMP).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genome Pharmaceutical Industry.